MALLORY WYRICK: Open Payments
NPI 1184487407 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 77 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $511 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 8 | $306 |
| AstraZeneca Pharmaceuticals LP | 9 | $172 |
| Mallinckrodt Hospital Products Inc. | 2 | $153 |
| Novo Nordisk Inc | 6 | $153 |
| Otsuka America Pharmaceutical, Inc. | 3 | $150 |
| Calliditas Therapeutics US Inc. | 6 | $147 |
| Travere Therapeutics, Inc. | 6 | $144 |
| GENZYME CORPORATION | 4 | $114 |
| Amgen Inc. | 4 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
Products named: ENVARSUS, JYNARQUE, TARPEYO, TERLIVAZ, Rivfloza, FABRAZYME, KRYSTEXXA, LIVTENCITY.
Industry payments across TX — which companies pay providers there.
